Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early vs Late G-CSF for Prophylaxis in NHL
NCT06665737Phase 4Not yet recruiting
- Sponsor
- Ministry of Public Health
- Start
- Feb 2025
- Primary completion
- Feb 2026
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of granulocyte colony-stimulating factor in febrile neutropenia (FN), sponsored by Ministry of Public Health. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
granulocyte colony-stimulating factor
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT06665737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06665737.